You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Efficacy of second-line regimens for Helicobacter pylori eradication treatment: a systemic review and network meta-analysis

Article info

Article menu

Download PDFPDF

Helicobacter pylori
Efficacy of second-line regimens for Helicobacter pylori eradication treatment: a systemic review and network meta-analysis

Authors

  • Yen-Lin Chang Department of Pharmacy, Taichung Veterans General Hospital, Taichung, TaiwanEvidence-based Practice and Policymaking Committee, Taichung Veterans General Hospital, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • Yu-Chun Tung Evidence-based Practice and Policymaking Committee, Taichung Veterans General Hospital, Taichung, TaiwanDepartment of Pharmacy, Puli Branch, Taichung Veterans General Hospital, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • Yu-Kang Tu Department of Medical Research, National Taiwan University Hospital, Taipei, TaiwanInstitute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, TaiwanDepartment of Dentistry, National Taiwan University Hospital and School of Dentistry, National Taiwan University, Taipei, Taiwan PubMed articlesGoogle scholar articles
  • Hong-Zen Yeh Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • Jyh-Chin Yang Division of Gastroenterology, Department of Internal Medicine, Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan PubMed articlesGoogle scholar articles
  • Ping-I Hsu Division of Gastroenterology, Department of Internal Medicine, An Nan Hospital, China Medical University, Tainan, Taiwan PubMed articlesGoogle scholar articles
  • Sung-Eun Kim Division of Gastroenterology, Department of Internal Medicine, Kosin University College of Medicine, Busan, South Korea PubMed articlesGoogle scholar articles
  • Ming-Fen Wu Department of Pharmacy, Taichung Veterans General Hospital, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • Wen-Shyong Liou Department of Pharmacy, Taichung Veterans General Hospital, Taichung, TaiwanSchool of Pharmacy, China Medical University, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • Sz-Iuan Shiu Evidence-based Practice and Policymaking Committee, Taichung Veterans General Hospital, Taichung, TaiwanDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, TaiwanDepartment of Critical Care Medicine, Taichung Veterans General Hospital, Taichung, Taiwan PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Sz-Iuan Shiu; b9002007{at}hotmail.com
View Full Text

Citation

Chang Y, Tung Y, Tu Y, et al
Efficacy of second-line regimens for Helicobacter pylori eradication treatment: a systemic review and network meta-analysis
BMJ Open Gastroenterology 2020;7:e000472. doi: 10.1136/bmjgast-2020-000472

Publication history

  • Received June 28, 2020
  • Revised July 16, 2020
  • Accepted July 29, 2020
  • First published September 3, 2020.
Online issue publication 
January 08, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.